Navigation Links
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
Date:4/1/2008

risks and uncertainties relating to the performance of our products; the growth in revenues; the size, timing and success or failure of any clinical trials for HIV drugs, such as Progenics' drug mentioned in this release; the risk that our Trofile Assay may not be utilized for patient use with CCR5 inhibitors; our ability to successfully conduct clinical studies and the results obtained from those studies; our ability to establish reliable, high-volume operations at commercially reasonable costs; expected reliance on a few customers for the majority of our revenues; the annual renewal of certain customer agreements; actual market acceptance of our products and adoption of our technological approach and products by pharmaceutical and biotechnology companies; our estimate of the size of our markets; our estimates of the levels of demand for our products; the impact of competition; the timing and ultimate size of pharmaceutical company clinical trials; whether payers will authorize reimbursement for our products and services and the amount of such reimbursement that may be allowed; whether the FDA or any other agency will decide to further regulate our products or services, including Trofile; whether the draft guidance on Multivariate Index Assays issued by FDA will be subsequently determined to apply to our current or planned products; whether we will encounter problems or delays in automating our processes; the ultimate validity and enforceability of our patent applications and patents; the possible infringement of the intellectual property of others; whether licenses to third party technology will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, Merrill Lynch and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to raise sufficient capital in the future, if required. For a discussion of ot
'/>"/>
SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium
2. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
3. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  Sage Analytics ( ... of equipment for the testing of marijuana potency ... the new Luminary™ Profiler, the industry,s first product ... in a cost-effective, portable unit. Designed ... needs of the cannabis industry, the Luminary™ Profiler ...
(Date:12/19/2014)... 18, 2014 Baptist Health Lexington is the first ... receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status ... Atrial fibrillation is the most common cardiac arrhythmia and has ... can lead to stroke and possible death. More than 5 ... have atrial fibrillation and the numbers are rapidly increasing as ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with the growth ... a later starter. In 2012, the size of ... with the proportion worldwide soaring to 16.3%. It is projected ... continue its growth rate by around 20% in the upcoming ... roughly RMB25 billion. An integrated membrane industrial system ...
Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... compression clothing distributor, recently added three new lymphedema ... Solaris and Gottfried are now available online through the ... used in lymphedema treatment. Lymphedema is a medical condition ... Although it can be caused by a genetic condition, ...
... MADISON, N.J. and CYPRESS, Calif., May 5, 2011 Quest ... provider of diagnostic testing, information and services, today announced the ... Universal Direct test on the 3M™ Integrated Cycler. The new ... enables fast, high volume lab testing, eliminating the traditional extraction ...
Cached Medicine Technology:BrightLife Direct Introduces 3 New Lymphedema Product Lines 2Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe 2Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe 3Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe 4
(Date:12/19/2014)... (HealthDay News) -- All children should have their eyesight ... every year, eye experts say. The new vision-screening ... of the U.S. National Center for Children,s Vision Health. ... group require screening for eye problems, particularly vision ... ("lazy eye") and strabismus (a disorder of eye alignment). ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Injectable drug users who ... suicide attempt rate of other substance users, a new ... associated with the risk of suicide attempt and completed ... of Montreal, said in a university news release. "However, ... wanted to know who among substance users were actually ...
(Date:12/19/2014)... -- The cost of cancer treatment can cause financial ... Researchers examined data from 1,000 people in the ... lung cancer. Of those patients, almost 900 had finished ... had advanced cancer. Nearly half of the patients ... which was linked with a poorer health-related quality of ...
(Date:12/19/2014)... Surviving Mesothelioma says thousands of water pipes ... these pipes can leach asbestos into drinking water as they ... on the Surviving Mesothelioma website. , According to ... deposits, decaying water mains made of asbestos cement are the ... protect consumers from mesothelioma , water providers are subject ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, ... the United States -- along with Angelina Jolie,s chickenpox ... highlighted cracks in the nation,s public health defense against ... released Thursday. Half of U.S. states are poorly ... outbreaks. That was the main conclusion of the report ...
Breaking Medicine News(10 mins):Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4
... to approve naming the women,s hospital -- located within the C.S. ... Jane Von Voigtlander , ANN ARBOR, Mich., Dec. 14 ... gift from the Ted and Jane Von Voigtlander Foundation, the largest ... will support the construction of a new women,s hospital. , The ...
... published in the December issue of Mayo Clinic ... disorder myelofibrosis. This retrospective study is the largest ever ... Myelofibrosis is a serious disorder that disrupts the body,s ... scarring in the bone marrow, leading to severe anemia, ...
... liver inflammation in cancer patients, researchers say , MONDAY, ... thistle, appears to reduce liver damage resulting from chemotherapy, ... liver inflammation, making it necessary to lower the dose ... in therapy can make treatment less effective, the researchers ...
... , WASHINGTON, Dec. 14 ... factors affecting youth violence, with more than 30 percent ... music provoke violence. Gangs, drugs and bullying are also ... to the National Campaign to Stop Violence. , (Photo: ...
... (UC) nephrologists shows that most dialysis patients admitted to ... and those with acute kidney failure don,t often recover ... in the advanced online edition of the American ... the National Kidney Foundation. "Acute kidney failure occurs ...
... ... rate. , ... York, NY (Vocus) December 14, 2009 -- PearlinBrite®, a unique in-office laser whitening system ... 100% tooth whitening success in the majority of cases” to-date, according to ...
Cached Medicine News:Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5Health News:Herb May Counter Liver Damage From Chemo 2Health News:Herb May Counter Liver Damage From Chemo 3Health News:Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence 2Health News:Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence 3Health News:Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence 4Health News:Hospital re-admission high for dialysis patients treated in long-term care hospitals 2Health News:Tooth Whitening System Designed by Dr. Jan Linhart Revealed as Highly Effective 2Health News:Tooth Whitening System Designed by Dr. Jan Linhart Revealed as Highly Effective 3
Insertion forcep used for the Hydroview lens. Manufactured in titanium....
... Curvilinear design and reduced ... Offers excellent control of IOL ... periphery of the optic. Curved ... tips gently curved. Smooth, flat, ...
2.5 mm cups angled 50 degrees, 10 mm from angle to tip. Serrated handle with polished finish....
Tennant straight tying forceps, 6.0 mm tying platforms, with pin, extra delicate smooth jaws....
Medicine Products: